Azitra (AZTR) Capital Leases (2023 - 2025)
Azitra (AZTR) reported Capital Leases of $1479.0 for Q2 2025, down 91.93% on a YoY basis from $18329.0 in Q2 2024, and down 74.69% quarter-over-quarter from $5843.0 in Q1 2025.
Azitra (AZTR) Capital Leases (2023 - 2025) Analysis & Trends
Azitra has reported Capital Leases for 3 years, with the latest figure at $1479.0 in Q2 2025.
- For the quarter ending Q2 2025, Capital Leases fell 91.93% year-over-year to $1479.0; the trailing twelve-month figure through Jun 2025 stood at $1479.0 (down 91.93% YoY), and the FY2024 full-year result was $10105.0, down 61.39% from the prior year.
- Capital Leases for Q2 2025 stood at $1479.0, down from $5843.0 in the prior quarter.
- The five-year high for Capital Leases was $29952.0 in Q3 2023, with the low at $1479.0 in Q2 2025.
- Historically, Capital Leases has averaged $16054.9 across 3 years, with a median of $16297.5 in 2024.
- Annual changes were most pronounced in 2024 — Capital Leases slumped 52.37% — and 2025, when it plunged 91.93%.
- Azitra's Capital Leases stood at $26169.0 in 2023, then plunged by 61.39% to $10105.0 in 2024, then slumped by 85.36% to $1479.0 in 2025.
- The last three Capital Leases figures came in at $1479.0 (Q2 2025), $5843.0 (Q1 2025), and $10105.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,479.00 |
| Mar 31, 2025 | 5,843.00 |
| Dec 31, 2024 | 10,105.00 |
| Sep 30, 2024 | 14,266.00 |
| Jun 30, 2024 | 18,329.00 |
| Mar 31, 2024 | 22,296.00 |
| Dec 31, 2023 | 26,169.00 |
| Sep 30, 2023 | 29,952.00 |